This work is licensed under the Creative Commons Attribution 4.0 International License.
Galiè N, Humbert M, Vachiery JL, et al; ESC Scientific Document Group. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016;37(1):67-119.GalièNHumbertMVachieryJLet al; ESC Scientific Document Group2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)20163716711910.1093/eurheartj/ehv31726320113Search in Google Scholar
Galiè N, Channick RN, Frantz RP, et al. Risk stratification and medical therapy of pulmonary arterial hypertension. Eur Respir J. 2019;53(1):1801889.GalièNChannickRNFrantzRPet alRisk stratification and medical therapy of pulmonary arterial hypertension2019531180188910.1183/13993003.01889-2018635134330545971Search in Google Scholar
Konstam MA, Kiernan MS, Bernstein D, et al C; American Heart Association Council on Clinical Cardiology; Council on Cardiovascular Disease in the Young; and Council on Cardiovascular Surgery and Anesthesia. Evaluation and management of right-sided heart failure: a scientific statement from the American Heart Association. Circulation. 2018;137(20):e578-e622.KonstamMAKiernanMSBernsteinDet alC; American Heart Association Council on Clinical Cardiology; Council on Cardiovascular Disease in the Young; and Council on Cardiovascular Surgery and Anesthesia. Evaluation and management of right-sided heart failure: a scientific statement from the American Heart Association201813720e578e622Search in Google Scholar
Haddad F, Doyle R, Murphy DJ, Hunt SA. Right ventricular function in cardiovascular disease, part II: pathophysiology, clinical importance, and management of right ventricular failure. Circulation. 2008;117(13):1717-31.HaddadFDoyleRMurphyDJHuntSARight ventricular function in cardiovascular disease, part II: pathophysiology, clinical importance, and management of right ventricular failure20081171317173110.1161/CIRCULATIONAHA.107.65358418378625Search in Google Scholar
Nowroozpoor A, Malekmohammad M, Seyyedi SR, Hashemian SM. Pulmonary hypertension in intensive care units: an updated review. Tanaffos. 2019;18(3):180-207.NowroozpoorAMalekmohammadMSeyyediSRHashemianSMPulmonary hypertension in intensive care units: an updated review2019183180207Search in Google Scholar
Bauchmuller K, Condliffe R, Southern J, et al. Critical care outcomes in patients with pre-existing pulmonary hypertension: insights from the ASPIRE registry. ERJ Open Res. 2021;7(2):00046-2021.BauchmullerKCondliffeRSouthernJet alCritical care outcomes in patients with pre-existing pulmonary hypertension: insights from the ASPIRE registry20217200046202110.1183/23120541.00046-2021802180233834051Search in Google Scholar
Huynh TN, Weigt SS, Sugar CA, Shapiro S, Kleerup EC. Prognostic factors and outcomes of patients with pulmonary hypertension admitted to the intensive care unit. J Crit Care. 2012;27(6):739.e7-13.HuynhTNWeigtSSSugarCAShapiroSKleerupECPrognostic factors and outcomes of patients with pulmonary hypertension admitted to the intensive care unit2012276739e7-1310.1016/j.jcrc.2012.08.00623089677Search in Google Scholar
Saydain G, Awan A, Manickam P, Kleinow P, Badr S. Pulmonary hypertension an independent risk factor for death in intensive care unit: correlation of hemodynamic factors with mortality. Clin Med Insights Circ Respir Pulm Med. 2015;9:27-33.SaydainGAwanAManickamPKleinowPBadrSPulmonary hypertension an independent risk factor for death in intensive care unit: correlation of hemodynamic factors with mortality20159273310.4137/CCRPM.S22199447916726124692Search in Google Scholar
Sztrymf B, Souza R, Bertoletti L, et al. Prognostic factors of acute heart failure in patients with pulmonary arterial hypertension. Eur Respir J. 2010;35(6):1286-93.SztrymfBSouzaRBertolettiLet alPrognostic factors of acute heart failure in patients with pulmonary arterial hypertension201035612869310.1183/09031936.0007020919897557Search in Google Scholar
Jentzer JC, Mathier MA. Pulmonary hypertension in the intensive care unit. J Intensive Care Med. 2016;31(6):369-85.JentzerJCMathierMAPulmonary hypertension in the intensive care unit20163163698510.1177/088506661558365225944777Search in Google Scholar
Kurzyna M, Zyłkowska J, Fijałkowska A, et al. Characteristics and prognosis of patients with decompensated right ventricular failure during the course of pulmonary hypertension. Kardiol Pol. 2008;66(10):1033-9.KurzynaMZyłkowskaJFijałkowskaAet alCharacteristics and prognosis of patients with decompensated right ventricular failure during the course of pulmonary hypertension2008661010339Search in Google Scholar
Campo A, Mathai SC, Le Pavec J, et al. Outcomes of hospitalisation for right heart failure in pulmonary arterial hypertension. Eur Respir J. 2011;38(2):359-67.CampoAMathaiSCLe PavecJet alOutcomes of hospitalisation for right heart failure in pulmonary arterial hypertension20113823596710.1183/09031936.0014831021310884Search in Google Scholar
Haddad F, Fuh E, Peterson T, et al. Incidence, correlates, and consequences of acute kidney injury in patients with pulmonary arterial hypertension hospitalized with acute right-side heart failure. J Cardiac Fail. 2011;17(7):533-9.HaddadFFuhEPetersonTet alIncidence, correlates, and consequences of acute kidney injury in patients with pulmonary arterial hypertension hospitalized with acute right-side heart failure2011177533910.1016/j.cardfail.2011.03.00321703524Search in Google Scholar
Torbic H. Management of pulmonary arterial hypertension in the ICU. J Pharm Pract. 2019;32(3):303-13.TorbicHManagement of pulmonary arterial hypertension in the ICU20193233031310.1177/089719001983811030909801Search in Google Scholar
Olsson KM, Halank M, Egenlauf B, et al. Decompensated right heart failure, intensive care and perioperative management in patients with pulmonary hypertension: Updated recommendations from the Cologne Consensus Conference 2018. Int J Cardiol. 2018;272S:46-52.OlssonKMHalankMEgenlaufBet alDecompensated right heart failure, intensive care and perioperative management in patients with pulmonary hypertension: Updated recommendations from the Cologne Consensus Conference 20182018272S465210.1016/j.ijcard.2018.08.08130190155Search in Google Scholar
Hoeper MM, Benza RL, Corris P, et al. Intensive care, right ventricular support and lung transplantation in patients with pulmonary hypertension. Eur Respir J. 2019;53(1):1801906.HoeperMMBenzaRLCorrisPet alIntensive care, right ventricular support and lung transplantation in patients with pulmonary hypertension2019531180190610.1183/13993003.01906-2018635138530545979Search in Google Scholar
Morrell NW, Aldred MA, Chung WK, et al. Genetics and genomics of pulmonary arterial hypertension. Eur Respir J. 2019;53(1):1801899.MorrellNWAldredMAChungWKet alGenetics and genomics of pulmonary arterial hypertension2019531180189910.1183/13993003.01899-2018635133730545973Search in Google Scholar
Hemnes AR, Beck GJ, Newman JH, et al; PVDOMICS Study Group. PVDOMICS: A multi-center study to improve understanding of pulmonary vascular disease through phenomics. Circ Res. 2017;121(10):1136-9.HemnesARBeckGJNewmanJHet alPVDOMICS Study Group. PVDOMICS: A multi-center study to improve understanding of pulmonary vascular disease through phenomics2017121101136910.1161/CIRCRESAHA.117.311737568556129074534Search in Google Scholar
Georgescu AM, Moldovan C, Szederjesi J, Georgescu D, Azamfirei L. Echocardiographic characteristics of pulmonary arterial hypertension in children with horizontally transmitted HIV. Adv Clin Exp Med. 2017;26(3):475-81.GeorgescuAMMoldovanCSzederjesiJGeorgescuDAzamfireiLEchocardiographic characteristics of pulmonary arterial hypertension in children with horizontally transmitted HIV20172634758110.17219/acem/6224428791823Search in Google Scholar
Weatherald J, Reis A, Sitbon O, Humbert M. Pulmonary arterial hypertension registries: past, present and into the future. Eur Respir Rev. 2019;28(154):190128.WeatheraldJReisASitbonOHumbertMPulmonary arterial hypertension registries: past, present and into the future20192815419012810.1183/16000617.0128-201931852747Search in Google Scholar
Swinnen K, Quarck R, Godinas L, Belge C, Delcroix M. Learning from registries in pulmonary arterial hypertension: pitfalls and recommendations. Eur Respir Rev. 2019;28(154):190050.SwinnenKQuarckRGodinasLBelgeCDelcroixMLearning from registries in pulmonary arterial hypertension: pitfalls and recommendations20192815419005010.1183/16000617.0050-201931852746Search in Google Scholar
Maron BA, Galiè N. Diagnosis, treatment, and clinical management of pulmonary arterial hypertension in the contemporary era: A Review. JAMA Cardiol. 2016;1(9):1056-65.MaronBAGalièNDiagnosis, treatment, and clinical management of pulmonary arterial hypertension in the contemporary era: A Review20161910566510.1001/jamacardio.2016.4471517749127851839Search in Google Scholar
McLaughlin VV, Archer SL, Badesch DB, et al; American College of Cardiology Foundation Task Force on Expert Consensus Documents; American Heart Association; American College of Chest Physicians; American Thoracic Society, Inc; Pulmonary Hypertension Association. ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol. 2009;53(17):1573-619.McLaughlinVVArcherSLBadeschDBet alAmerican College of Cardiology Foundation Task Force on Expert Consensus Documents; American Heart Association; American College of Chest Physicians; American Thoracic Society, Inc; Pulmonary Hypertension Association. ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association20095317157361910.1016/j.jacc.2009.01.00419389575Search in Google Scholar
Farber HW, Miller DP, Poms AD, et al. Five-year outcomes of patients enrolled in the REVEAL Registry. Chest. 2015;148(4):1043-54.FarberHWMillerDPPomsADet alFive-year outcomes of patients enrolled in the REVEAL Registry2015148410435410.1378/chest.15-030026066077Search in Google Scholar
Sitbon O, Sattler C, Bertoletti L, et al. Initial dual oral combination therapy in pulmonary arterial hypertension. Eur Respir J. 2016;47(6):1727-36.SitbonOSattlerCBertolettiLet alInitial dual oral combination therapy in pulmonary arterial hypertension201647617273610.1183/13993003.02043-201526989105Search in Google Scholar
Badesch DB, Raskob GE, Elliott CG, et al. Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry. Chest. 2010;137(2):376-87.BadeschDBRaskobGEElliottCGet alPulmonary arterial hypertension: baseline characteristics from the REVEAL Registry201013723768710.1378/chest.09-114019837821Search in Google Scholar
Humbert M, Sitbon O, Chaouat A, et al. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med. 2006;173(9):1023-30.HumbertMSitbonOChaouatAet alPulmonary arterial hypertension in France: results from a national registry2006173910233010.1164/rccm.200510-1668OC16456139Search in Google Scholar
Peacock AJ, Murphy NF, McMurray JJ, Caballero L, Stewart S. An epidemiological study of pulmonary arterial hypertension. Eur Respir J. 2007;30(1):104-9.PeacockAJMurphyNFMcMurrayJJCaballeroLStewartSAn epidemiological study of pulmonary arterial hypertension2007301104910.1183/09031936.0009230617360728Search in Google Scholar
McGoon MD, Benza RL, Escribano-Subias P. Pulmonary arterial hypertension: epidemiology and registries. J Am Coll Cardiol. 2013;62(25 Suppl):D51-9.McGoonMDBenzaRLEscribano-SubiasPPulmonary arterial hypertension: epidemiology and registries20136225 SupplD51910.21693/1933-088X-13.1.21Search in Google Scholar
Bergot E, De Leotoing L, Bendjenana H, et al. Hospital burden of pulmonary arterial hypertension in France. PLoS One. 2019;14(9):e0221211.BergotEDe LeotoingLBendjenanaHet alHospital burden of pulmonary arterial hypertension in France2019149e022121110.1371/journal.pone.0221211675279731536491Search in Google Scholar
D’Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med. 1991;115(5):343-9.D’AlonzoGEBarstRJAyresSMet alSurvival in patients with primary pulmonary hypertension19911155343910.7326/0003-4819-115-5-3431863023Search in Google Scholar
Humbert M, Sitbon O, Yaïci A, et al; French pulmonary arterial hypertension network. Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension. Eur Respir J. 2010;36(3):549-55.HumbertMSitbonOYaïciAet alFrench pulmonary arterial hypertension network. Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension20103635495510.1183/09031936.0005701020562126Search in Google Scholar
Thenappan T, Shah SJ, Rich S, Tian L, Archer SL, Gomberg-Maitland M. Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation. Eur Respir J. 2010;35(5):1079-87.ThenappanTShahSJRichSTianLArcherSLGomberg-MaitlandMSurvival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation201035510798710.1183/09031936.00072709878256420032020Search in Google Scholar
Silber D, Lachmann J. Invasive hemodynamics of pulmonary disease and the right ventricle. Interv Cardiol Clin. 2017;6(3):329-43.SilberDLachmannJInvasive hemodynamics of pulmonary disease and the right ventricle2017633294310.1016/j.iccl.2017.03.00428600088Search in Google Scholar
Moscucci M (ed). Grossman & Baim’s Cardiac Catheterization, Angiography, and Intervention, Wolters Kluwer, 9 th Ed., 2021.MoscucciM(ed)2021Search in Google Scholar
Benza RL, Gomberg-Maitland M, Elliott CG, et al. Predicting survival in patients with pulmonary arterial hypertension: The REVEAL risk score calculator 2.0 and comparison with ESC/ERS-based risk assessment strategies. Chest. 2019;156(2):323-37.BenzaRLGomberg-MaitlandMElliottCGet alPredicting survival in patients with pulmonary arterial hypertension: The REVEAL risk score calculator 2.0 and comparison with ESC/ERS-based risk assessment strategies201915623233710.1016/j.chest.2019.02.00430772387Search in Google Scholar
Benza RL, Kanwar MK, Raina A, et al. Development and validation of an abridged version of the REVEAL 2.0 risk score calculator, REVEAL Lite 2, for use in patients with pulmonary arterial hypertension. Chest. 2021;159(1):337-46.BenzaRLKanwarMKRainaAet alDevelopment and validation of an abridged version of the REVEAL 2.0 risk score calculator, REVEAL Lite 2, for use in patients with pulmonary arterial hypertension202115913374610.1016/j.chest.2020.08.2069746263932882243Search in Google Scholar
Boucly A, Weatherald J, Savale L, et al. Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension. Eur Respir J. 2017;50(2):1700889.BouclyAWeatheraldJSavaleLet alRisk assessment, prognosis and guideline implementation in pulmonary arterial hypertension2017502170088910.1183/13993003.00889-201728775050Search in Google Scholar
Ranchoux B, Harvey LD, Ayon RJ, et al. Endothelial dysfunction in pulmonary arterial hypertension: an evolving landscape (2017 Grover Conference Series). Pulm Circ. 2018;8(1):2045893217752912.RanchouxBHarveyLDAyonRJet alEndothelial dysfunction in pulmonary arterial hypertension: an evolving landscape (2017 Grover Conference Series)201881204589321775291210.1177/2045893217752912579869129283043Search in Google Scholar
Yildiz M, Sahin A, Behnes M, Akin İ. An expanding role of biomarkers in pulmonary arterial hypertension. Curr Pharm Biotechnol. 2017;18(6):491-4.YildizMSahinABehnesMAkinİAn expanding role of biomarkers in pulmonary arterial hypertension2017186491410.2174/138920101866617061508251028641568Search in Google Scholar
Kanwar MK. Biomarkers in pulmonary arterial hypertension: Moving closer toward precision medicine? J Heart Lung Transplant. 2020;39(4):287-8.KanwarMKBiomarkers in pulmonary arterial hypertension: Moving closer toward precision medicine?2020394287810.1016/j.healun.2020.02.02032199588Search in Google Scholar
Fijalkowska A, Kurzyna M, Torbicki A, et al. Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension. Chest. 2006;129(5):1313-21.FijalkowskaAKurzynaMTorbickiAet alSerum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension2006129513132110.1378/chest.129.5.131316685024Search in Google Scholar
Warwick G, Thomas PS, Yates DH. Biomarkers in pulmonary hypertension. Eur Respir J. 2008;32(2):503-12.WarwickGThomasPSYatesDHBiomarkers in pulmonary hypertension20083225031210.1183/09031936.0016030718669790Search in Google Scholar
Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016;18(8):891-975.PonikowskiPVoorsAAAnkerSDet al2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC201618889197510.1002/ejhf.59227207191Search in Google Scholar
Rubio-Gracia J, Giménez-López I, Josa-Laorden C, et al. Prognostic value of multimodal assessment of congestion in acute heart failure. Rev Clin Esp (Barc). 2021;221(4):198-206.Rubio-GraciaJGiménez-LópezIJosa-LaordenCet alPrognostic value of multimodal assessment of congestion in acute heart failure2021221419820610.1016/j.rceng.2019.10.01333998498Search in Google Scholar
Pezzuto B, Badagliacca R, Poscia R, et al. Circulating biomarkers in pulmonary arterial hypertension: update and future direction. J Heart Lung Transplant. 2015;34:282-305.PezzutoBBadagliaccaRPosciaRet alCirculating biomarkers in pulmonary arterial hypertension: update and future direction20153428230510.1016/j.healun.2014.12.00525682555Search in Google Scholar
Hemnes AR. Current and emerging biomarkers for pulmonary hypertension. Adv Pulm Hypertens. 2018;16:136-40.HemnesARCurrent and emerging biomarkers for pulmonary hypertension2018161364010.21693/1933-088X-16.3.136Search in Google Scholar
Simpson CE, Damico RL, Hassoun PM, et al. Noninvasive prognostic biomarkers for left-sided heart failure as predictors of survival in pulmonary arterial hypertension. Chest. 2020;157(6):1606-16.SimpsonCEDamicoRLHassounPMet alNoninvasive prognostic biomarkers for left-sided heart failure as predictors of survival in pulmonary arterial hypertension2020157616061610.1016/j.chest.2019.12.037726844631987881Search in Google Scholar
Samokhin AO, Stephens T, Wertheim BM, et al. NEDD9 targets COL3A1 to promote endothelial fibrosis and pulmonary arterial hypertension. Sci Transl Med. 2018;10(445):eaap7294.SamokhinAOStephensTWertheimBMet alNEDD9 targets COL3A1 to promote endothelial fibrosis and pulmonary arterial hypertension201810445eaap729410.1126/scitranslmed.aap7294622302529899023Search in Google Scholar
Coons JC, Pogue K, Kolodziej AR, Hirsch GA, George MP. Pulmonary arterial hypertension: a pharmacotherapeutic update. Curr Cardiol Rep. 2019;21(11):141.CoonsJCPogueKKolodziejARHirschGAGeorgeMPPulmonary arterial hypertension: a pharmacotherapeutic update2019211114110.1007/s11886-019-1235-431758342Search in Google Scholar
Dodson MW, Brown LM, Elliott CG. Pulmonary arterial hypertension. Heart Fail Clin. 2018;14(3):255-69.DodsonMWBrownLMElliottCGPulmonary arterial hypertension20181432556910.1016/j.hfc.2018.02.00329966625Search in Google Scholar
Price LC, Dimopoulos K, Marino P, et al. The CRASH report: emergency management dilemmas facing acute physicians in patients with pulmonary arterial hypertension. Thorax. 2017;72(11):1035-45.PriceLCDimopoulosKMarinoPet alThe CRASH report: emergency management dilemmas facing acute physicians in patients with pulmonary arterial hypertension2017721110354510.1136/thoraxjnl-2016-20972528904006Search in Google Scholar
Cassady SJ, Ramani GV. Right heart failure in pulmonary hypertension. Cardiol Clin. 2020;38(2):243-55.CassadySJRamaniGVRight heart failure in pulmonary hypertension20203822435510.1016/j.ccl.2020.02.00132284101Search in Google Scholar
Siehr SL, Ivy DD, Miller-Reed K, Ogawa M, Rosenthal DN, Feinstein JA. Children with pulmonary arterial hypertension and prostanoid therapy: long-term hemodynamics. J Heart Lung Transplant. 2013;32(5):546-52.SiehrSLIvyDDMiller-ReedKOgawaMRosenthalDNFeinsteinJAChildren with pulmonary arterial hypertension and prostanoid therapy: long-term hemodynamics20133255465210.1016/j.healun.2013.01.1055376015923453572Search in Google Scholar
Sandoval J. Interventional therapies in pulmonary hypertension. Rev Esp Cardiol (Engl Ed). 2018;71(7):565-74.SandovalJInterventional therapies in pulmonary hypertension20187175657410.1016/j.rec.2018.02.00229545075Search in Google Scholar
Vonk Noordegraaf A, Haddad F, Chin KM, et al. Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology. J Am Coll Cardiol. 2013;62:D22-33.VonkNoordegraaf AHaddadFChinKMet alRight heart adaptation to pulmonary arterial hypertension: physiology and pathobiology201362D223310.1016/j.jacc.2013.10.02724355638Search in Google Scholar
Vonk Noordegraaf A, Chin KM, Haddad F, et al. Pathophysiology of the right ventricle and of the pulmonary circulation in pulmonary hypertension: an update. Eur Respir J. 2019;53(1):1801900.VonkNoordegraaf AChinKMHaddadFet alPathophysiology of the right ventricle and of the pulmonary circulation in pulmonary hypertension: an update2019531180190010.1183/13993003.01900-2018635134430545976Search in Google Scholar
Mehra MR, Park MH, Landzberg MJ, Lala A, Waxman AB; International Right Heart Failure Foundation Scientific Working Group. Right heart failure: toward a common language. J Heart Lung Transplant. 2014;33(2):123-6.MehraMRParkMHLandzbergMJLalaAWaxmanABInternational Right Heart Failure Foundation Scientific Working Group. Right heart failure: toward a common language2014332123610.1016/j.healun.2013.10.01524268184Search in Google Scholar
Harjola VP, Mebazaa A, Čelutkienė J, et al. Contemporary management of acute right ventricular failure: a statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology. Eur J Heart Fail. 2016;18(3):226-41.HarjolaVPMebazaaAČelutkienėJet alContemporary management of acute right ventricular failure: a statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology20161832264110.1002/ejhf.47826995592Search in Google Scholar
Inampudi C, Tedford RJ, Hemnes AR, et al. Treatment of right ventricular dysfunction and heart failure in pulmonary arterial hypertension. Cardiovasc Diagn Ther. 2020;10(5):1659-74.InampudiCTedfordRJHemnesARet alTreatment of right ventricular dysfunction and heart failure in pulmonary arterial hypertension202010516597410.21037/cdt-20-348766695633224779Search in Google Scholar
Sanders JL, Koestenberger M, Rosenkranz S, Maron BA. Right ventricular dysfunction and long-term risk of death. Cardiovasc Diagn Ther. 2020;10(5):1646-58.SandersJLKoestenbergerMRosenkranzSMaronBARight ventricular dysfunction and long-term risk of death202010516465810.21037/cdt-20-450766695733224778Search in Google Scholar
Hermens JA, Donker DW. Right ventricular failure in the ICU: a practical approach. Neth J Crit Care. 2018;26(3):111-7.HermensJADonkerDWRight ventricular failure in the ICU: a practical approach20182631117Search in Google Scholar
Rajagopalan N, Dohi K, Simon MA, et al. Right ventricular dyssynchrony in heart failure: a tissue Doppler imaging study. J Card Fail. 2006;12(4):263-7.RajagopalanNDohiKSimonMAet alRight ventricular dyssynchrony in heart failure: a tissue Doppler imaging study2006124263710.1016/j.cardfail.2006.02.00816679258Search in Google Scholar
Vitarelli A, Mangieri E, Terzano C, et al. Three-dimensional echocardiography and 2D-3D speckle-tracking imaging in chronic pulmonary hypertension: diagnostic accuracy in detecting hemodynamic signs of right ventricular (RV) failure. J Am Heart Assoc. 2015;4(3):e001584.VitarelliAMangieriETerzanoCet alThree-dimensional echocardiography and 2D-3D speckle-tracking imaging in chronic pulmonary hypertension: diagnostic accuracy in detecting hemodynamic signs of right ventricular (RV) failure201543e00158410.1161/JAHA.114.001584439243825792128Search in Google Scholar
Marik PE. Obituary: pulmonary artery catheter 1970 to 2013. Ann Intensive Care. 2013;3(1):38.MarikPEObituary: pulmonary artery catheter 1970 to 20132013313810.1186/2110-5820-3-38417548224286266Search in Google Scholar
de Asua I, Rosenberg A. On the right side of the heart: Medical and mechanical support of the failing right ventricle. J Intensive Care Soc. 2017;18(2):113-20.deAsua IRosenbergAOn the right side of the heart: Medical and mechanical support of the failing right ventricle20171821132010.1177/1751143716684357560642228979557Search in Google Scholar
Litton E, Morgan M. The PiCCO monitor: a review. Anaesth Intensive Care. 2012;40(3):393-409.LittonEMorganMThe PiCCO monitor: a review201240339340910.1177/0310057X120400030422577904Search in Google Scholar
Pearse RM, Ikram K, Barry J. Equipment review: an appraisal of the LiDCO plus method of measuring cardiac output. Crit Care. 2004;8(3):190-5.PearseRMIkramKBarryJEquipment review: an appraisal of the LiDCO plus method of measuring cardiac output200483190510.1186/cc285246889915153237Search in Google Scholar
Sharma RK, Oliveira AC, Yang T, et al. Pulmonary arterial hypertension-associated changes in gut pathology and microbiota. ERJ Open Res. 2020;6(3):00253-2019.SharmaRKOliveiraACYangTet alPulmonary arterial hypertension-associated changes in gut pathology and microbiota20206300253201910.1183/23120541.00253-2019738305432743008Search in Google Scholar
Ranchoux B, Bigorgne A, Hautefort A, et al. Gut-lung connection in pulmonary arterial hypertension. Am J Respir Cell Mol Biol. 2017;56(3):402-5.RanchouxBBigorgneAHautefortAet alGut-lung connection in pulmonary arterial hypertension2017563402510.1165/rcmb.2015-0404LE28248132Search in Google Scholar
Bandorski D, Bogossian H, Stempfl J, et al. Prognostic relevance of nonsustained ventricular tachycardia in patients with pulmonary hypertension. Biomed Res Int. 2016;2016:1327265.BandorskiDBogossianHStempflJet alPrognostic relevance of nonsustained ventricular tachycardia in patients with pulmonary hypertension20162016132726510.1155/2016/1327265520640828090536Search in Google Scholar
Cannillo M, Grosso Marra W, et al. Supraventricular arrhythmias in patients with pulmonary arterial hypertension. Am J Cardiol. 2015;116(12):1883-9.CannilloMGrossoMarra Wet alSupraventricular arrhythmias in patients with pulmonary arterial hypertension2015116121883910.1016/j.amjcard.2015.09.03926522342Search in Google Scholar
Middleton JT, Maulik A, Lewis R, et al. Arrhythmic burden and outcomes in pulmonary arterial hypertension. Front Med (Lausanne). 2019;6:169.MiddletonJTMaulikALewisRet alArrhythmic burden and outcomes in pulmonary arterial hypertension2019616910.3389/fmed.2019.00169666400031396515Search in Google Scholar
Mercurio V, Peloquin G, Bourji KI, et al. Pulmonary arterial hypertension and atrial arrhythmias: incidence, risk factors, and clinical impact. Pulm Circ. 2018;8(2):2045894018769874.MercurioVPeloquinGBourjiKIet alPulmonary arterial hypertension and atrial arrhythmias: incidence, risk factors, and clinical impact201882204589401876987410.1177/2045894018769874591229129575972Search in Google Scholar
Olsson KM, Nickel NP, Tongers J, Hoeper MM. Atrial flutter and fibrillation in patients with pulmonary hypertension. Int J Cardiol. 2013;167(5):2300-5.OlssonKMNickelNPTongersJHoeperMMAtrial flutter and fibrillation in patients with pulmonary hypertension201316752300510.1016/j.ijcard.2012.06.02422727973Search in Google Scholar
Granton J, Mercier O, De Perrot M. Management of severe pulmonary arterial hypertension. Semin Respir Crit Care Med. 2013;34(5):700-13.GrantonJMercierODePerrot MManagement of severe pulmonary arterial hypertension20133457001310.1055/s-0033-1356460Search in Google Scholar
Cirulis MM, Ryan JJ, Archer SL. Pathophysiology, incidence, management, and consequences of cardiac arrhythmia in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. Pulm Circ. 2019;9(1):2045894019834890.CirulisMMRyanJJArcherSLPathophysiology, incidence, management, and consequences of cardiac arrhythmia in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension201991204589401983489010.1177/2045894019834890Search in Google Scholar
Bandorski D, Bogossian H, Ghofrani A, Schmitt J, Höltgen R. Tachykardien bei pulmonalarterieller hypertonie [Tachycardia and pulmonary arterial hypertension]. Herzschrittmacherther Elektrophysiol. 2020;31(1):33-8.BandorskiDBogossianHGhofraniASchmittJHöltgenRTachykardien bei pulmonalarterieller hypertonie [Tachycardia and pulmonary arterial hypertension]202031133810.1007/s00399-020-00668-wSearch in Google Scholar
Grünig E, Benjamin N, Krüger U, et al. General measures and supportive therapy for pulmonary arterial hypertension: Updated recommendations from the Cologne Consensus Conference 2018. Int J Cardiol. 2018;272S:30-6.GrünigEBenjaminNKrügerUet alGeneral measures and supportive therapy for pulmonary arterial hypertension: Updated recommendations from the Cologne Consensus Conference 20182018272S30610.1016/j.ijcard.2018.08.085Search in Google Scholar
Ponikowski P, Kirwan BA, Anker SD, et al; AFFIRM-AHF investigators. Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial. Lancet. 2020;396(10266):1895-904.PonikowskiPKirwanBAAnkerSDet alAFFIRM-AHF investigators. Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial202039610266189590410.1016/S0140-6736(20)32339-4Search in Google Scholar
DeFilippis EM, Van Spall HGC. In acute HF and iron deficiency, IV ferric carboxymaltose reduced HF hospitalizations, but not CV death, at 1 y. Ann Intern Med. 2021;174(4):JC45.DeFilippisEMVanSpall HGCIn acute HF and iron deficiency, IV ferric carboxymaltose reduced HF hospitalizations, but not CV death, at 1 y20211744JC4510.7326/ACPJ202104200-04533819065Search in Google Scholar
Thibault N, Morrill AM, Willett KC. Idarucizumab for Reversing Dabigatran-Induced Anticoagulation: A Systematic Review. Am J Ther. 2018;25(3):e333-e338.ThibaultNMorrillAMWillettKCIdarucizumab for Reversing Dabigatran-Induced Anticoagulation: A Systematic Review2018253e333e33810.1097/MJT.000000000000046027175894Search in Google Scholar
Carpenter E, Singh D, Dietrich E, Gums J. Andexanet alfa for reversal of factor Xa inhibitor-associated anticoagulation. Ther Adv Drug Saf. 2019;10:2042098619888133.CarpenterESinghDDietrichEGumsJAndexanet alfa for reversal of factor Xa inhibitor-associated anticoagulation201910204209861988813310.1177/2042098619888133688002831807265Search in Google Scholar
Moen CA, Burrell A, Dunning J. Does tranexamic acid stop haemoptysis? Interact Cardiovasc Thorac Surg. 2013;17(6):991-4.MoenCABurrellADunningJDoes tranexamic acid stop haemoptysis?2013176991410.1093/icvts/ivt383382950023966576Search in Google Scholar
Cantu J, Wang D, Safdar Z. Clinical implications of haemoptysis in patients with pulmonary arterial hypertension. Int J Clin Pract Suppl. 2012;(177):5-12.CantuJWangDSafdarZClinical implications of haemoptysis in patients with pulmonary arterial hypertension201217751210.1111/ijcp.12004400178222943513Search in Google Scholar
Franquiz MJ, Hines MC, Yeung SYA. Comparison of Two Weight-Based Desmopressin Dosing Strategies for Spontaneous Bleeding. Ann Pharmacother. 2018;52(6):527-32.FranquizMJHinesMCYeungSYAComparison of Two Weight-Based Desmopressin Dosing Strategies for Spontaneous Bleeding20185265273210.1177/106002801775235429332421Search in Google Scholar
Konstantinides SV, Meyer G, Becattini C, et al; ESC Scientific Document Group. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 2020;41(4):543-603.KonstantinidesSVMeyerGBecattiniCet alESC Scientific Document Group. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS202041454360310.1093/eurheartj/ehz40531504429Search in Google Scholar
Roberts DH, Lepore JJ, Maroo A, et al. Oxygen therapy improves cardiac index and pulmonary vascular resistance in patients with pulmonary hypertension. Chest 2001;120:1547-55.RobertsDHLeporeJJMarooAet alOxygen therapy improves cardiac index and pulmonary vascular resistance in patients with pulmonary hypertension200112015475510.1378/chest.120.5.154711713133Search in Google Scholar
Price LC, Wort SJ, Finney SJ, Marino PS, Brett SJ. Pulmonary vascular and right ventricular dysfunction in adult critical care: current and emerging options for management: a systematic literature review. Crit Care. 2010;14(5):R169.PriceLCWortSJFinneySJMarinoPSBrettSJPulmonary vascular and right ventricular dysfunction in adult critical care: current and emerging options for management: a systematic literature review2010145R16910.1186/cc9264321926620858239Search in Google Scholar
Needham DM, Colantuoni E, Mendez-Tellez PA, et al. Lung protective mechanical ventilation and two year survival in patients with acute lung injury: prospective cohort study. BMJ. 2012;344:e2124.NeedhamDMColantuoniEMendez-TellezPAet alLung protective mechanical ventilation and two year survival in patients with acute lung injury: prospective cohort study2012344e212410.1136/bmj.e2124332056622491953Search in Google Scholar
Rush B, Biagioni BJ, Berger L, McDermid R. Mechanical ventilation outcomes in patients with pulmonary hypertension in the United States: A National Retrospective Cohort Analysis. J Intensive Care Med. 2017;32(10):588-92.RushBBiagioniBJBergerLMcDermidRMechanical ventilation outcomes in patients with pulmonary hypertension in the United States: A National Retrospective Cohort Analysis201732105889210.1177/088506661665392627279084Search in Google Scholar
Bansal S, Lindenfeld J, Schrier RW. Sodium retention in heart failure and cirrhosis: potential role of natriuretic doses of mineralocorticoid antagonist? Circ Heart Fail. 2009;2(4):370-6.BansalSLindenfeldJSchrierRWSodium retention in heart failure and cirrhosis: potential role of natriuretic doses of mineralocorticoid antagonist?200924370610.1161/CIRCHEARTFAILURE.108.82119919808361Search in Google Scholar
Felker GM, Mentz RJ. Diuretics and ultrafiltration in acute decompensated heart failure. J Am Coll Cardiol. 2012;59(24):2145-53.FelkerGMMentzRJDiuretics and ultrafiltration in acute decompensated heart failure2012592421455310.1016/j.jacc.2011.10.91022676934Search in Google Scholar
Sitbon O, Vonk Noordegraaf A. Epoprostenol and pulmonary arterial hypertension: 20 years of clinical experience. Eur Respir Rev. 2017;26(143):160055.SitbonOVonkNoordegraaf AEpoprostenol and pulmonary arterial hypertension: 20 years of clinical experience20172614316005510.1183/16000617.0055-201628096285Search in Google Scholar
Sitbon O, Channick R, Chin KM, et al; GRIPHON Investigators. Selexipag for the treatment of pulmonary arterial hypertension. N Engl J Med. 2015;373(26):2522-33.SitbonOChannickRChinKMet alGRIPHON Investigators. Selexipag for the treatment of pulmonary arterial hypertension20153732625223310.1056/NEJMoa150318426699168Search in Google Scholar
Vachiery JL, Huez S, Gillies H, et al. Safety, tolerability and pharmacokinetics of an intravenous bolus of sildenafil in patients with pulmonary arterial hypertension. Br J Clin Pharmacol 2011;71(2):289-92.VachieryJLHuezSGilliesHet alSafety, tolerability and pharmacokinetics of an intravenous bolus of sildenafil in patients with pulmonary arterial hypertension20117122899210.1111/j.1365-2125.2010.03831.x304055121219411Search in Google Scholar
Sitbon O, Jais X, Savale L, et al. Upfront triple combination therapy in pulmonary arterial hypertension: a pilot study. Eur Respir J 2014;43:1691-7.SitbonOJaisXSavaleLet alUpfront triple combination therapy in pulmonary arterial hypertension: a pilot study2014431691710.1183/09031936.0011631324627535Search in Google Scholar
Appleton C, Gillam L, Koulogiannis K. Cardiac Tamponade. Cardiol Clin. 2017;35(4):525-37.AppletonCGillamLKoulogiannisKCardiac Tamponade20173545253710.1016/j.ccl.2017.07.00629025544Search in Google Scholar
Schmidt M, Burrell A, Roberts L, et al. Predicting survival after ECMO for refractory cardiogenic shock: the survival after venoarterial-ECMO (SAVE)-score. Eur Heart J. 2015;36(33):2246-56.SchmidtMBurrellARobertsLet alPredicting survival after ECMO for refractory cardiogenic shock: the survival after venoarterial-ECMO (SAVE)-score2015363322465610.1093/eurheartj/ehv19426033984Search in Google Scholar